Net Cash Provided by (Used in) Operating Activities |
-25.2K |
USD |
+18.4% |
Jul 31, 2023 |
Q2 2023 |
Net Cash Provided by (Used in) Financing Activities |
25.5K |
USD |
-15% |
Jul 31, 2023 |
Q2 2023 |
Common Stock, Shares Authorized |
600M |
shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Common Stock, Shares, Issued |
9.08M |
shares |
+843% |
Jan 31, 2024 |
Q4 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
304 |
USD |
-96.1% |
Jan 31, 2024 |
Q4 2023 |
Deferred Tax Assets, Valuation Allowance |
1.59M |
USD |
+48.3% |
Apr 30, 2023 |
Q1 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Apr 30, 2023 |
Q1 2023 |
Deferred Tax Assets, Gross |
1.59M |
USD |
+48.3% |
Apr 30, 2023 |
Q1 2023 |
Depreciation |
0 |
USD |
-100% |
Jan 31, 2024 |
Q4 2023 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Jan 31, 2024 |
Q4 2023 |
Additional Paid in Capital |
15.1M |
USD |
+2.8% |
Jan 31, 2024 |
Q4 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Apr 30, 2023 |
Q1 2023 |
Interest Expense |
6.77K |
USD |
-20.5% |
Jan 31, 2024 |
Q4 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Jan 31, 2024 |
Q4 2023 |